Alastair Kerr
Senior Research Specialist
E-mail: alastair.kerr@ki.se
Telephone: +46852481005
Visiting address: C2:94, Karolinska Universitetssjukhuset Huddinge, 14186 Stockholm
Postal address: H7 Medicin, Huddinge, H7 CeRM Kerr, 171 77 Stockholm
About me
- Alastair is a group leader in the Unit of Endocrinology at the Department of Medicine-Huddinge. Alastair's group uses human white adipose tissue biopsies and large population genetic studies coupled with advanced molecular methods to uncover how disease relevant long non-coding RNA function in fat cells.
Alastair Kerr received his PhD from the University of Oxford in 2017 before completing his postdoctoral studies at the Karolinska Institutet in the laboratories of Prof. Peter Arner and Dr. Ingrid Dahlman. Here he examined how long non-coding RNAs function in human adipocytes to regulate lipid metabolism. During the post-doctoral work Alastair, discovered the long non-coding RNA, ADIPINT, to be a regulator of the lipid mass in adipocytes through interaction with the metabolic enzyme pyruvate carboxylase. He is the inventor of the method TROOPS, which allows the identification of interacting proteins for a given lncRNA.
Articles
- Journal article: DIABETES. 2025;:db250222Schormair K; Zhong J; Rico LDM; Wang N; Dahlman I; Arner P; Kerr AG
- Journal article: EUROPEAN HEART JOURNAL. 2025;46(20):1881-1882Kerr AG
- Article: CLINICAL NUTRITION. 2024;43(2):468-475Kerr AG; Andersson DP; Ryden M; Arner P
- Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2023;43(6):1054-1065Kerr AG; Andersson DP; Dahlman I; Ryden M; Arner P
- Article: NATURE COMMUNICATIONS. 2023;14(1):1438Massier L; Jalkanen J; Elmastas M; Zhong J; Wang T; Nankam PAN; Frendo-Cumbo S; Backdahl J; Subramanian N; Sekine T; Kerr AG; Tseng BTP; Laurencikiene J; Buggert M; Lourda M; Kublickiene K; Bhalla N; Andersson A; Valsesia A; Astrup A; Blaak EE; Stahl PL; Viguerie N; Langin D; Wolfrum C; Blueher M; Ryden M; Mejhert N
- Article: DIABETES. 2023;72(3):316-325Andersson DP; Kerr AG; Dahlman I; Ryden M; Arner P
- Article: INTERNATIONAL JOURNAL OF OBESITY. 2022;46(6):1196-1203Arner P; Andersson DP; Arner E; Ryden M; Kerr AG
- Article: NATURE COMMUNICATIONS. 2022;13(1):2958Kerr AG; Wang Z; Wang N; Kwok KHM; Jalkanen J; Ludzki A; Lecoutre S; Langin D; Bergo MO; Dahlman I; Mim C; Arner P; Gao H
- Article: NATURE METABOLISM. 2022;4(2):190-202Maqdasy S; Lecoutre S; Renzi G; Frendo-Cumbo S; Rizo-Roca D; Moritz T; Juvany M; Hodek O; Gao H; Couchet M; Witting M; Kerr A; Bergo MO; Choudhury RP; Aouadi M; Zierath JR; Krook A; Mejhert N; Ryden M
- Article: JOURNAL OF INTERNAL MEDICINE. 2020;288(2):219-233Kerr AG; Andersson DP; Ryden M; Arner P; Dahlman I
- Article: MOLECULAR METABOLISM. 2019;25:159-167Kerr AG; Sinha I; Dadvar S; Arner P; Dahlman I
- Article: ATHEROSCLEROSIS. 2018;276:74-82Patel J; Douglas G; Kerr AG; Hale AB; Channon KM
- Article: EBIOMEDICINE. 2018;30:248-260Gao H; Kerr A; Jiao H; Hon C-C; Ryden M; Dahlman I; Arner P
- Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2018;103(2):710-721Petrus P; Bialesova L; Checa A; Kerr A; Naz S; Backdahl J; Gracia A; Toft S; Dahlman-Wright K; Heden P; Dahlman I; Wheelock CE; Arner P; Mejhert N; Gao H; Ryden M
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2017;361(3):417-428Kerr AG; Tam LCS; Hale AB; Cioroch M; Douglas G; Agkatsev S; Hibbitt O; Mason J; Holt-Martyn J; Bataille CJR; Wynne GM; Channon KM; Russell AJ; Wade-Martins R
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2016;5(11):e383Kerr AG; Tam LCS; Hale AB; Cioroch M; Douglas G; Channon KM; Wade-Martins R
All other publications
- Preprint: RESEARCH SQUARE. 2021Kerr A; Kwok K; Ludzki A; Langin D; Dahlman I; Arner P; Gao H
Grants
- Swedish Research Council
- Novo Nordisk Foundation
- European Foundation for the Study of Diabetes
- Åke Wiberg Stiftelse
- Magnus Bergvalls Stiftelse
- Karolinska Institutet